Intervention Review

Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease

  1. Arturo J Martí-Carvajal1,*,
  2. Ivan Solà2,
  3. Graciela Nicita3

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 17 DEC 2008

DOI: 10.1002/14651858.CD006007.pub2

Database Title

Additional Information

How to Cite

Martí-Carvajal AJ, Solà I, Nicita G. Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD006007. DOI: 10.1002/14651858.CD006007.pub2.

Author Information

  1. 1

    Iberoamerican Cochrane Network, Valencia, Edo. Carabobo, Venezuela

  2. 2

    Hospital de la Santa Creu i Sant Pau, Iberoamerican Cochrane Centre, Barcelona, Catalunya, Spain

  3. 3

    Universidad de Carabobo, Valencia, Venezuela

*Arturo J Martí-Carvajal, Iberoamerican Cochrane Network, Valencia, Edo. Carabobo, 2001, Venezuela. arturo.marti.carvajal@gmail.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 20 JAN 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (62K)Standard (242K)Full (253K)

  1. Current Version

    Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease

    Arturo J Martí-Carvajal, Ivan Solà and Graciela Nicita

    Article first published online: 20 JAN 2010 | DOI: 10.1002/14651858.CD006007.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease

    AJ Marti-Carvajal and JL Pérez-Requejo

    Article first published online: 18 OCT 2006 | DOI: 10.1002/14651858.CD006007

View Full Article (HTML) Summary (62K)Standard (242K)Full (253K)